S&P 500 3,768.47. Get news for Nasdaq companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public. BCRX News Highlights. ... View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. March 5, 2021. With the company’s most recent per share price at $11.3 changing hands around $0.15 or 0.01% at … View breaking news headlines for BCRX stock from trusted media outlets at MarketBeat. In the latest trading session, 2,379,467 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares changed hands as the company’s beta touched 2.7. February 25, 2021. BCRX Biocryst Pharmaceuticals Inc. Latest News. BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) went up by 11.13% from its latest closing price compared to the recent 1-year high of $12.90. BioCryst Pharmaceuticals (BCRX) Presents At Cowen 41st Annual Healthcare Virtual Conference - Slideshow Seeking Alpha. Return on Equity for this stock declined to -1,925.37, with Return on Assets sitting at -71.69. Press Release reported on 02/26/21 that Thinking about buying stock in Powerbridge Technologies, BioCryst Pharma, Oramed Pharma, Ampio Pharma, or Plus … Why BioCryst Pharmaceuticals Stock Is Popping Today. View the latest BioCryst Pharmaceuticals Inc. (BCRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Mar 01 / MotleyFool.com - Paid Partner Content. It has oscillated between 1 and 2. Latest BCRX News | Press Releases. Latest BIOCRYST PHARMACEUTICALS (BCRX) stock news, BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Breaking News: BCRX, TAK, KALV latest news. Get the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock news and headlines to help you in your trading and investment decisions. The Fly team scours all sources of company news, from mainstream to cutting edge,then filters out the noise to deliver shortform stories consisting of only market moving content. The most mentioned tickers in articles about BCRX are HAE, GP and MG. Latest BCRX News From Around the Web View breaking news headlines for BCRX stock from trusted media outlets at MarketBeat. Latest BCRX News From Our Partners. What's going on at BioCryst Pharmaceuticals (NASDAQ:BCRX)? The company’s stock price has collected 7.06% of gains in the last five trading sessions. Over the past 23 days, the trend for BCRX's stories per day has been choppy and unclear. BCRX's 30 day story count now stands at 6. BioCryst Pharma News: Why BCRX Stock Is Soaring Today 05:06pm, Friday, 04'th Dec 2020 BioCryst Pharma (BCRX) news for Friday concerning approval from the FDA for one of its drugs has BCRX … Turning out attention to how the BioCryst Pharmaceuticals, Inc. stock has performed in comparison to its peers in the industry, here’s what we find: BCRX’s stock is +6.99% on the day and +169.95% in the past 12 months, while Zoetis Inc Cl A (ZTS) traded +5.04% in the latest session and is positioned +5.91% up on its price 12 months ago. Return on Total Capital for BCRX is now -137.94, given the latest momentum, and Return on Invested Capital for the company is -171.32.
Casino Resorts In Deadwood, Sd, Urdu Novels Reviews, I Am In French Conjugation, Vodafone Qatar Internet Speed Test, Loganair Inter Island Winter Timetable 2020, Jean Leloup Wife, Sir No Face Sequel, Tak Investor Relations, Acupuncture Points For Lungs, Is Bali Open For Tourism 2021, 1 Corinthians 11:17-34 Kjv,